NCT00370240 - Chlorhydrate of Ropivacaine and Breast Cancer Surgery | Biotech Hunter

Enrollment

260

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

November 30, 2008

Conditions

Breast NeoplasmsPain,Postoperative

Interventions

DRUG

Chlorhydrate de Ropivacaine

The Ropivacaïne group received 3mg/kg of 0.375% ropivacaïne(0.75% ropivacaïne, Astra, mixed with saline)

OTHER

placebo

The PCB group received saline solution in equal volume.

Trial Locations (1)

René Huguenin Center, Saint-Cloud